UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of ISBT 128 embedded in the single european code in the contract manufacture of cryopreserved hematopoietic stem cells

Cytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S45-S45

2019

Volltextzugriff (PDF)

Validated transportation systems for cell based products

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S146-S146

2017

Volltextzugriff (PDF)

Therapeutic angiogenesis - design and first results of pre-clinical study

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S54-S54

2013

Volltextzugriff (PDF)

203 - Validated transportation systems for cell based products

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S146-S146

2017

Volltextzugriff (PDF)

Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1808-1814

2013

Volltextzugriff (PDF)

The Metabolism of the New Benzodiazepine Remimazolam

Current drug metabolism, 2024-01, Vol.25 (2), p.164-173

2024

Volltextzugriff (PDF)

Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein Binding

Current drug metabolism, 2024-01, Vol.25 (4), p.266-275

2024

Volltextzugriff (PDF)

Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys

European journal of pharmacology, 2021-01, Vol.890, p.173639, Article 173639

2021

Volltextzugriff (PDF)

Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: In-Vitro Studies and Literature Review

Current drug metabolism, 2024-08, Vol.25

2024

Volltextzugriff (PDF)

Linkage-specific ubiquitin binding interfaces modulate the activity of the chlamydial deubiquitinase Cdu1 towards poly-ubiquitin substrates

PLoS pathogens, 2024-10, Vol.20 (10), p.e1012630

2024

Volltextzugriff (PDF)

A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis

Experimental neurology, 2007-10, Vol.207 (2), p.350-356

2007

Volltextzugriff (PDF)

Monoclonal antibody G250 targeting CA IX: Binding specificity, internalization and therapeutic effects in a non-renal cancer model

International journal of oncology, 2014-12, Vol.45 (6), p.2455-2467

2014

Volltextzugriff (PDF)

Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037

Cancer chemotherapy and pharmacology, 2016-12, Vol.78 (6), p.1269-1281

2016

Volltextzugriff (PDF)

Inhibition of Cytochromes P4501A by Nitric Oxide

Proceedings of the National Academy of Sciences - PNAS, 1994-04, Vol.91 (9), p.3559-3563

1994

Volltextzugriff (PDF)

Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils Via Mac-1, But Independently of Urokinase-Type Plasminogen Activator Receptor

Circulation (New York, N.Y.), 2011-10, Vol.124 (17), p.1848-1859

2011

Volltextzugriff (PDF)

Activation of the anti-cancer agent upamostat by the mARC enzyme system

Xenobiotica, 2013-09, Vol.43 (9), p.780-784

2013

Volltextzugriff (PDF)

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread

FEBS letters, 2002-09, Vol.528 (1), p.212-216

2002

Volltextzugriff (PDF)

Non-viral gene-transfer medicinal product – design and results of GLP pre-clinical study

Cytotherapy (Oxford, England), 2015-06, Vol.17 (6), p.S53-S53

2015

Volltextzugriff (PDF)

Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant

The journal of gene medicine, 1999-09, Vol.1 (5), p.331-340

1999

Volltextzugriff (PDF)

Small, Potent, and Selective Diaryl Phosphonate Inhibitors for Urokinase-Type Plasminogen Activator with In Vivo Antimetastatic Properties

Journal of medicinal chemistry, 2007-12, Vol.50 (26), p.6638-6646

2007

Volltextzugriff (PDF)

A phase I, first-in-human single ascending dose study of the MEK inhibitor WX-554 given to healthy male subjects

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13666-e13666

2010

Volltextzugriff (PDF)

Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics

Journal of medicinal chemistry, 2002-11, Vol.45 (23), p.4984-4994

2002

Volltextzugriff (PDF)

The ethanol-inducible YAT1 gene from yeast encodes a presumptive mitochondrial outer carnitine acetyltransferase

The Journal of biological chemistry, 1993-12, Vol.268 (36), p.27428-27439

1993

Volltextzugriff (PDF)

Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, wxc-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases

British journal of cancer, 2007-01, Vol.96 (2), p.262-268

2007

Volltextzugriff (PDF)

Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines

Drug metabolism and disposition, 1996-12, Vol.24 (12), p.1314

1996

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(53)

Sprache

Englisch
(51)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(26)
Animals
(25)
Biological And Medical Sciences
(16)
Pharmacology & Pharmacy
(14)
Cell Line
(10)
Medical Sciences
(10)
Cricetinae
(9)
Rats
(8)
Transfection
(8)
Biochemistry & Molecular Biology
(7)
Cricetulus
(6)
Female
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Genetic Vectors
(6)
Mice
(6)
Toxicology
(6)
Biotransformation
(5)
Pharmacology. Drug Treatments
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Use of ISBT 128 embedded in the single european code in the contract manufacture of cryopreserved hematopoietic stem cells

Validated transportation systems for cell based products

Therapeutic angiogenesis - design and first results of pre-clinical study

203 - Validated transportation systems for cell based products

Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

The Metabolism of the New Benzodiazepine Remimazolam

Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein Binding

Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys

Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: In-Vitro Studies and Literature Review

Linkage-specific ubiquitin binding interfaces modulate the activity of the chlamydial deubiquitinase Cdu1 towards poly-ubiquitin substrates

A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis

Monoclonal antibody G250 targeting CA IX: Binding specificity, internalization and therapeutic effects in a non-renal cancer model

Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037

Inhibition of Cytochromes P4501A by Nitric Oxide

Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils Via Mac-1, But Independently of Urokinase-Type Plasminogen Activator Receptor

Activation of the anti-cancer agent upamostat by the mARC enzyme system

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread

Non-viral gene-transfer medicinal product – design and results of GLP pre-clinical study

Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant

Small, Potent, and Selective Diaryl Phosphonate Inhibitors for Urokinase-Type Plasminogen Activator with In Vivo Antimetastatic Properties

A phase I, first-in-human single ascending dose study of the MEK inhibitor WX-554 given to healthy male subjects

Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics

The ethanol-inducible YAT1 gene from yeast encodes a presumptive mitochondrial outer carnitine acetyltransferase

Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, wxc-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases

Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines

Suchergebnisse filtern